Terms: = Germ cell tumor AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394 AND Treatment
19 results:
1. Dexamethasone Inhibits Heparan Sulfate Biosynthetic System and Decreases Heparan Sulfate Content in Orthotopic Glioblastoma tumors in Mice.
Sokolov DK; Shevelev OB; Khotskina AS; Tsidulko AY; Strokotova AV; Kazanskaya GM; Volkov AM; Kliver EE; Aidagulova SV; Zavjalov EL; Grigorieva EV
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373391
[TBL] [Abstract] [Full Text] [Related]
2. Effective dose window for containing tumor burden under tolerable level.
Masud MA; Kim JY; Kim E
NPJ Syst Biol Appl; 2023 May; 9(1):17. PubMed ID: 37221258
[TBL] [Abstract] [Full Text] [Related]
3.
Kim M; Kim Y; Lee HW; Jung JC; Oh S
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986039
[TBL] [Abstract] [Full Text] [Related]
4. Exostosin 1 Knockdown Induces Chemoresistance in MV3 Melanoma cells by Upregulating JNK and MEK/ERK Signaling.
Pfeifer V; Weber H; Wang Y; Schlesinger M; Gorzelanny C; Bendas G
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982528
[TBL] [Abstract] [Full Text] [Related]
5. Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy.
Nicolai N; Nazzani S; Tesone A; Macchi A; Piva L; Salvioni R; Stagni S; Torelli T; Agostini E; Celso F; Giannatempo P; Procopio G; Avuzzi B; Lanocita R; Cattaneo L; Catanzaro M; Biasoni D
Tumori; 2023 Aug; 109(4):379-386. PubMed ID: 35915559
[TBL] [Abstract] [Full Text] [Related]
6. Evaluating Quality Indicators of Glioblastoma Care: Audit Results From an Indian Tertiary Care Cancer Center.
Basu Achari R; Chakraborty S; Goyal L; Saha S; Roy P; Zameer L; Mishra D; Parihar M; Das A; Chandra A; Biswas B; Mallick I; Arunsingh MA; Chatterjee S; Bhattacharyya T
JCO Glob Oncol; 2022 Mar; 8():e2100405. PubMed ID: 35298293
[TBL] [Abstract] [Full Text] [Related]
7. The association of BMI and sarcopenia with survival in patients with glioblastoma multiforme.
Guven DC; Aksun MS; Cakir IY; Kilickap S; Kertmen N
Future Oncol; 2021 Nov; 17(32):4405-4413. PubMed ID: 34409854
[No Abstract] [Full Text] [Related]
8. Evaluation of ttv replication as a biomarker of immune checkpoint inhibitors efficacy in melanoma patients.
Pescarmona R; Mouton W; Walzer T; Dalle S; Eberhardt A; Brengel-Pesce K; Villard M; Lombard C; Trouillet-Assant S; Viel S
PLoS One; 2021; 16(8):e0255972. PubMed ID: 34370787
[TBL] [Abstract] [Full Text] [Related]
9. Natural History of Growing Sporadic Vestibular Schwannomas During Observation: An International Multi-Institutional Study.
Marinelli JP; Carlson ML; Hunter JB; Nassiri AM; Haynes DS; Link MJ; Lohse CM; Reznitsky M; Stangerup SE; Caye-Thomasen P
Otol Neurotol; 2021 Sep; 42(8):e1118-e1124. PubMed ID: 34121081
[TBL] [Abstract] [Full Text] [Related]
10. The Effectiveness of Diffusion Tensor Imaging in Determining Radiological Response after Radiosurgery in Patients with Vestibular Schwannoma.
Cesme DH; Alkan A; Sari L; Kaya A; Yurtsever I; Alkan G; Seyithanoglu MH; Hatiboglu MA
Curr Med Imaging; 2021; 17(5):602-607. PubMed ID: 33504315
[TBL] [Abstract] [Full Text] [Related]
11. Updated Outcome and Analysis of tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High-Dose Photon/Proton Radiation Therapy.
Kabolizadeh P; Chen YL; Liebsch N; Hornicek FJ; Schwab JH; Choy E; Rosenthal DI; Niemierko A; DeLaney TF
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):254-262. PubMed ID: 27986348
[TBL] [Abstract] [Full Text] [Related]
12. 3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma.
Schneider T; Chapiro J; Lin M; Geschwind JF; Kleinberg L; Rigamonti D; Jusué-Torres I; Marciscano AE; Yousem DM
Eur Radiol; 2016 Mar; 26(3):849-57. PubMed ID: 26139318
[TBL] [Abstract] [Full Text] [Related]
13. Management of intracranial and extracranial chordomas with CyberKnife stereotactic radiosurgery.
Jiang B; Veeravagu A; Lee M; Harsh GR; Lieberson RE; Bhatti I; Soltys SG; Gibbs IC; Adler JR; Chang SD
J Clin Neurosci; 2012 Aug; 19(8):1101-6. PubMed ID: 22727205
[TBL] [Abstract] [Full Text] [Related]
14. Repeated tumor oximetry to identify therapeutic window during metronomic cyclophosphamide treatment of 9L gliomas.
Mupparaju S; Hou H; Lariviere JP; Swartz H; Jounaidi Y; Khan N
Oncol Rep; 2011 Jul; 26(1):281-6. PubMed ID: 21503586
[TBL] [Abstract] [Full Text] [Related]
15. Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors.
Massironi S; Conte D; Sciola V; Spampatti MP; Ciafardini C; Valenti L; Rossi RE; Peracchi M
Am J Gastroenterol; 2010 Sep; 105(9):2072-8. PubMed ID: 20372113
[TBL] [Abstract] [Full Text] [Related]
16. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
Balzer BL; Ulbright TM
Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
[TBL] [Abstract] [Full Text] [Related]
17. Simultaneous radiochemotherapy in pediatric patients with high-grade glioma: a phase I study.
Wolff JE; Wagner S; Sindichakis M; Pietsch T; Gnekow A; Kortmann RD; Sträter R; Kuehl J
Anticancer Res; 2002; 22(6B):3569-72. PubMed ID: 12552957
[TBL] [Abstract] [Full Text] [Related]
18. Intratumoral infusion of topotecan prolongs survival in the nude rat intracranial U87 human glioma model.
Pollina J; Plunkett RJ; Ciesielski MJ; Lis A; Barone TA; Greenberg SJ; Fenstermaker RA
J Neurooncol; 1998 Sep; 39(3):217-25. PubMed ID: 9821107
[TBL] [Abstract] [Full Text] [Related]
19. Somatostatinoma: a case report and review of the literature.
Harris GJ; Tio F; Cruz AB
J Surg Oncol; 1987 Sep; 36(1):8-16. PubMed ID: 3041116
[TBL] [Abstract] [Full Text] [Related]
